Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Bullish +75

Intuitive Surgical Inc (NASDAQ:ISRG) Screens as a Strong Growth Stock with a Promising Technical Breakout Setup - ChartMill

📈 Intuitive Surgical (ISRG) combines fundamental strength with a promising technical setup, identified by a dual-discipline screening strategy.

💰 The company earned an 8/10 Growth rating, with EPS rising 25.92% and revenue expanding 20.51% over the past year.

🛡️ Financial health is exceptional, highlighted by a 9/10 ChartMill Health rating, zero outstanding debt, and a top-tier Altman-Z score of 40.00.

📊 Profitability remains robust with a 9/10 rating, allowing the firm to fund expansion without risky leverage while converting growth into earnings.

📉 Although the overall technical rating is low (1/10) due to negative long-term trends, the Setup Rating is solid at 8/10.

⚖️ Price has been consolidating between $448 and $491, currently hovering near a key resistance zone between $477.85 and $483.63.

🔁 A breakout above the resistance zone with strong volume could signal a reversal of the recent downtrend.

📈 A "Pocket Pivot" signal indicates volume-based accumulation by institutional buyers, reinforcing the potential for upward movement.

🛑 Investors can risk-manage the trade by setting stop-loss orders below the support zone around $453 to limit downside exposure.

🏥 Strong demand for the da Vinci and Ion surgical systems continues to drive the company's impressive top-line growth metrics.

📱 ChartMill lists ISRG in its fastest growing stocks screen due to high EPS and sales growth performance.

💹 ISRG is also featured on revenue growth leaders and High EPS Growth Stocks screens, confirming its status as a profitable health care leader.

⚠️ The analysis notes that even superior fundamentals are not a sufficient investment if the price or timing is incorrect.

🔍 This screening approach acts as a quality filter that specifically waits for favorable entry points based on technical configurations.

📜 All data and ratings are presented for informational purposes, with a disclaimer advising independent research or financial consultation.

Bullish Signals
  • Intuitive Surgical earned a Growth rating of 8 out of 10, with Earnings Per Share growing by 25.92% and revenue expanding by 20.51% over the past year.
  • The company carries no outstanding debt and achieved a ChartMill Health rating of 9 out of 10, supported by an Altman-Z score of 40.00 indicating near-zero risk of financial distress.
  • ISRG demonstrated strong profitability with a Profitability rating of 9 out of 10, effectively converting its rapid topline growth into real profits.
  • Technical analysis identifies a Setup Rating of 8 out of 10, suggesting the stock is consolidating near key resistance zones between $477.85 and $483.63 after trading in a range from roughly $448 to $491.
  • A recent 'Pocket Pivot' signal indicates that institutional buyers are stepping in to accumulate shares, adding weight to a potential price reversal.
  • The stock qualifies for multiple ChartMill screener lists including 'fastest growing stocks', 'revenue growth leaders', and 'High EPS Growth Stocks', highlighting its status as a market leader.
  • The risk/reward ratio is currently viewed as favorable, allowing investors to participate in a potential breakout while limiting downside by placing a stop-loss below the support zone around $453.
Risk Factors
  • The stock carries a poor overall technical rating of 1 out of 10 due to a negative long-term trend and 12-month underperformance relative to the broader market.
  • The company has been trading in a range between $448 and $491, hovering just below a key resistance zone which suggests limited upside potential until a decisive breakout occurs.
  • Despite a recent 'Pocket Pivot' signal, the setup relies on investors placing a stop-loss below the support zone around $453, which caps potential gains if the stock does not break out immediately.
  • The article warns that even strong fundamentals are insufficient if the stock is purchased at the wrong price or time, highlighting valuation risk as a major consideration.
Full Analysis
Intuitive Surgical Inc (NASDAQ: ISRG) has emerged as a notable candidate under a screening strategy that combines fundamental analysis with technical setups to identify high-potential growth stocks. This approach prioritizes companies demonstrating robust revenue and earnings growth alongside solid financial health, while simultaneously seeking specific technical configurations that suggest an impending price breakout. The company, recognized as a pioneer in robotic-assisted surgery using its da Vinci and Ion surgical systems, received a Growth rating of 8 out of 10 and a ChartMill Health rating of 9 out of 10 based on these criteria. Fundamentally, ISRG has shown impressive expansion with Earnings Per Share increasing by 25.92% over the past year and revenue growing by 20.51% in the same period. The company maintains a pristine financial balance sheet characterized by zero outstanding debt and a Profitability rating of 9 out of 10. Its Altman-Z score stands at 40.00, which is among the highest in the Health Care Equipment & Supplies industry, indicating a near-zero risk of financial distress. These metrics suggest the company is effectively converting growth into profit while retaining the ability to fund expansion without risky leverage. On the technical side, despite a poor overall rating of 1 out of 10 due to a negative long-term trend and 12-month underperformance relative to the broader market, ISRG presents a compelling opportunity based on its Setup Rating of 8 out of 10. The stock has been consolidating within a range between roughly $448 and $491, currently trading just below a key resistance zone between $477.85 and $483.63, which is reinforced by moving averages and trend lines. A "Pocket Pivot" volume-based accumulation signal suggests institutional buyer interest, and analysts note that a decisive break above the resistance with strong volume could signal a trend reversal. For investors, this setup allows for a favorable risk/reward ratio, with stop-loss orders potentially positioned below the support zone around $453. Consequently, ISRG is categorized in multiple ChartMill screener lists, including those for fastest growing stocks, revenue growth leaders, and high EPS growth stocks. The article emphasizes that while this combination of strong fundamentals and a clear technical entry point makes the stock a textbook candidate for quality-focused investors, it serves as an informational tool rather than direct investment advice. Past performance is noted not to guarantee future results, and the screening strategy aims to act as a filter that waits for favorable entry points by merging quality indicators with timing mechanics.